Document conversion software for enterprises: which solution should I choose?

Converting just a few documents to PDFs is easy and can be done via desktop tools. 

When you have 100.000s of documents to convert to PDF or PDF/A, choosing the right software for your business is crucial. We’ll explain the three most important features of document conversion software that adds value to your business.

  1.   It speeds up your conversion drastically 

Most organizations, without even realizing it, are not directly converting documents to PDF. Instead, they first have to open the source file in the application where the original document was created. This ‘authoring application’ can be a Microsoft Office application (Word, Excel, PowerPoint) or Adobe technology, for example. And then a PDF is created from those applications. This indirect process is significantly slowing down the whole document conversion. An ideal software that doesn’t need this intermediate step will work much quicker and is definitely the right choice for organizations with large volumes to convert.

The speed of your document conversion software is also impacted by its speed of enriching documents: adding headers, footers, bookmarks, table of content (TOC), hyperlinks, security, watermarks, … All these enrichments may be legal requirements, so you can’t go without them. 

Classically, the PDF document created will be uploaded to different tools in order to add all necessary elements. This manual work is not only increasing the risk of errors, but it’s also slowing you down. A conversion software that offers both conversion and enrichment capabilities, is clearly a lot faster and reduces your dependence on having other tools to enrich the documents. 

  1.   It reduces your costs in multiple ways

All authoring applications (such as MS Office or Adobe technology or AutoCAD etc.) require licenses. And these licenses come at a cost. Plus, the software also needs maintenance. If you can convert your documents directly without needing the original application, this will result in huge cost savings.

The same goes for OCR: extra tools, plug-ins and add-ons you might need to perform OCR on the converted documents. They also come with licensing costs. An all-in-one document conversion solution is not only much faster but will work great for your budget.

Have we mentioned the manual work? Document enrichment is very labor-intensive. Converting a Word document to PDF via Adobe takes no more than 5 seconds, but enriching (managing hyperlinks, adjusting zoom levels, adding headers & footers, watermarks, bookmarks, merging documents, creating searchable documents etc.) and re-routing it to the right repositories is the most time-consuming task of the document conversion process. If this has to be done for thousands of documents, you or your employees will spend lots of time (days or weeks probably) doing repetitive manual work that can be automated by an efficient document conversion software.

  1.   It should automate most of the things you do manually today

Avoiding manual work as much as you can: that’s where an ideal conversion software should add value. Downloading content manually to the computer desktop, for example from email repositories or document management systems, and then uploading it to the conversion tool? The right document conversion software can do much better: it will automatically take content from any location(s), convert it to desired formats and send it back to the right location(s)

Other manual steps can be eliminated too, such as the use of optical character recognition technology (OCR). Rather than having to use a separate OCR tool, the perfect document conversion software should have built-in OCR as part of the document conversion process. Saving you valuable time, while reducing your dependence on manual tools. 

This maximum automation in one platform will give you the greatest ease of use. You don’t need to check what the document will look like in Microsoft Word versus Adobe. No more wondering whether colors, titles and other settings will appear in the same way. You just control everything from one platform before converting documents. 

Every company needs an efficient document conversion solution. 

Many companies in different industries (insurance, banking, HR, automotive, aviation, life sciences and healthcare, IT integrators) use DocShifter to speed up and simplify their document conversion and enrichment. 

DocShifter software is 10x faster than comparable solutions, easier to use and doesn’t need authoring applications (MS Office, Adobe technology, AutoCAD etc.) to run. Saving you valuable time. Reducing your IT and infrastructure costs. Speeding up your operations. 

Looking for an automated document conversion software that can convert and enrich your 100.000s of documents at lightning speed? 

Contact us today or schedule a demo.  

6 Rocking Reasons to Rethink Document Rendering

We have been rendering various documents into a unified format such as PDF for many years now. For many reasons: ease of use, accessibility, a wide range of functionalities and many more. 

In knowledge-driven industries, the need for standardization is often forced by regulators. For example, in Life Sciences, the introduction of the electronic Common Technical Document (eCTD) has accelerated the move from paper to electronic formats; mainly to PDF.

In other industries, the need to archive documents has led to massive content transformation as well. Transformation to de facto standards such as PDF/A ensures that documents are secure for the long term. Read more

3 tips to save time and reduce risk in regulatory submissions

How can you speed up the process of getting your medicinal products approved by health authorities? At the same time, how can you reduce the risk of submitting PDFs that are not complying with technical requirements in your regulatory submissions? Our tips will help you streamline the whole regulatory submission process.

For Life Sciences companies, time is scarce when preparing to launch a new product. Anything that slows down your submission process and introduces a risk of a delay in gaining approval is hugely frustrating. Having your submission rejected by the health authorities because your PDFs don’t meet their technical requirements is time-consuming, financially expensive and negatively affects the company’s image. So here are a few tips on how to tackle this challenge, save time and reduce the risk of non-compliance.

Tip 1: Move compliance earlier in your regulatory submissions (don’t wait until submission time)

When creating PDFs manually or with many rendering tools, you typically need to edit them afterwards in order to meet each of the health authorities’ technical requirements where the content will be used. A regular PDF will not be compliant by default, so additional tools and steps are required to modify each and every PDF created to make it compliant, or wait until the very end of the submission process and let the publishing tool make those adjustments. This approach is time-consuming, means that technical issues are only discovered very late in the process, and increases the risk of making mistakes.

The solution to this problem is to ensure compliance is achieved at an earlier stage in your submission content preparation process. Compliance should actually be reached automatically when you render your content to PDF; not require any additional tools or manual steps, including for multiple Health Authorities if necessary. This enables a shift in focus on quality control, and reduces the number of issues being resolved after the publishing stage. 

Improve document lifecycle and start validating PDFs earlier in your regulatory content preparation process with DocShifter's automated PDF validation software

Tip 2: Automate (reduce the necessity of manually editing PDFs for regulatory submission compliance)

Enhanced efficiency and built-in compliance can only be achieved by using an automated PDF rendering system. Some of these systems can automatically render multiple versions of your PDFs, each meeting the technical requirements of a specific health authority such as the FDA (US), PMDA (Japan), EMA (Europe), Health Canada and Swiss Health. Differences can include the PDF version used, whether the PDFs are optimized for fast web viewing, the number of bookmark levels created and visible on opening, the colour of hyperlinks, whether bookmarks for tables and figures should be grouped together, and if documents exceeding a specific number of pages should automatically have a table of content added.

Many Life Sciences companies are still using desktop tools, such as Adobe Acrobat or DXCToolbox (formerly known as ISIToolbox), to manually edit thousands of PDFs for compliance. This manual editing is extremely time-consuming, repetitive and increases the risk of making mistakes. Automating compliant rendering can help whether you work in a specific market only or if you have a global portfolio of products.

solutions for your FDA submission

Tip 3: Centralize all your (compliant) PDF conversion/rendering

For a smooth approval process by health authorities, it is necessary to submit PDFs that are consistent technically and visually. This is difficult to achieve when using multiple technologies to create and manipulate your files. Each application can introduce inconsistencies, in particular when they can be configured differently by each user involved. 

A powerful system for automated compliant rendering will solve this problem. The PDF rendering engine retrieves the files from all your different controlled content repositories such as OpenText Documentum, Veeva Vault and Microsoft SharePoint, but also from file shares, web services and email repositories, and converts them to consistent and compliant PDFs, ready to be submitted to any health authority worldwide.

DocShifter can help you to reduce the risks of non-compliance, automate and centralize compliant document and PDF conversion.

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs. Rated 5 starts on Gartner’s Capterra platform. 

Track changes and comments don’t look consistent when you convert Microsoft Word documents to PDF?

Are you having trouble converting Microsoft Word documents containing track changes and comments to PDF?

Creating consistent output when converting MS Word documents containing track changes into PDF is a big challenge. With multiple reviewers and authors working on the same document, each with their styling, getting this consistency is almost an impossible mission

Do you continually have to edit the PDF to achieve the desired results?

The only way organizations can tackle this right now is manual: changing how the track changes should look like, once authors and reviewers finish editing the document. Considering the large volumes, this is extremely inefficient, slow, and time-consuming. 

It is a manually-intensive process that requires multiple edits in Microsoft Word to get the desired results. 

Force the track changes and comments to look a certain way, when creating PDFs. 

Why not automate this manual PDF editing process and fix inconsistencies much earlier? Why wait to make all these manual manipulations in the PDF document, one by one? Use an automated document conversion solution that can easily ensure consistency in your track changes and comments already from the Word documents. 

Did you know that DocShifter is able to guarantee all track changes and comments appear with a completely consistent look, no matter how the authors and reviewers added them in the original Word document? 

Different options for different scenarios. Do you want the comments to be shown or not? If yes, what style would you prefer: inline changes or in bubbles? All options will be centrally applied when rendering a Microsoft Word document that contains track changes and comments to PDF. Automated, fast, and risk-free.

This consistency ensures you can save valuable time and reduce manual work when sharing content both internally and externally.

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce risk. Reduce IT infrastructure costs.

Is data taking over the role of PDF in eCTD submissions?

The Life Sciences industry is dedicated to protecting the health of millions of individuals worldwide. The industry is also looking to improve their lives with affordable and easily accessible medicinal products. Patient and patient safety always comes first, which is why the process of bringing a drug to the market takes many years (from 8 to 14 years). 

To be able to launch a product, Life Sciences companies must comply with many regulatory requirements, starting from the first stage of research and product development through initial product commercialization.

Migration from paper-based submissions to e-dossiers

The process of submitting documents to regulatory authorities to receive approval for launching a new medicine dates back to the 1940s. Initially, these submissions were all on paper and consisted of small single-volume dossiers containing fewer than 100 pages. Over time, paper dossiers increased considerably both in complexity and size, making paper-format submissions no longer an appealing option.

The accessibility to information technology and the fast broadband Internet connection changed the way documentation and data were submitted. First introduced in 2003, the eCTD (electronic Common Technical Document) became the expected format for electronic submissions to Health Authorities (HAs) worldwide. 

However, the implementation process of the electronic submissions (both eCTD and NeeS – non-eCTD electronic submissions) by the global HAs took many years and was met with reluctance from the industry. In 2020, there are still 80 countries worldwide that file their submissions on paper. Even China, one of the most technologically advanced countries in the world, is only now implementing the eCTD submission format. Currently, the following countries accept eCTD submissions: the US, EU, Canada, Gulf Cooperation Council (Saudi Arabia, Oman, UAE, Bahrain), Jordan, Australia, Switzerland, South Africa, Thailand, and Japan.

Status of eCTD submission implementation worldwide

PDF vs. Data : The upcoming battle in eCTD submission format

Many other countries like China are just now implementing eCTD. To justify all that investment and effort, it will take them years before looking into alternatives to document and PDF submissions. The many regulations make the Life Sciences industry slow moving and understandably risk-averse. Every new process has to be approved, then validated, and finally implemented and this takes up many years.

However, some general discussions about the ongoing implementation process of IDMP (the European regulations on Identification of Medicinal Products) revealed a possible future alternative to the unstructured PDF format. IDMP is an initiative for patient safety and heavily focuses on structured data. Even though it has nothing to do with launching a new product, many companies hope that IDMP will be the beginning of a new era and allow electronic submissions to evolve into data submissions

While there is excellent potential to embrace data submissions, the Life Sciences industry is not ready for such a radical change in today’s reality. Just consider that not long ago, companies used to deliver hard-drives and laptops to the HA where the electronic submissions were stored. This process has evolved gradually over a long period of time, and nowadays, any type of electronic submissions is mostly filed in a PDF format. Given the slow adoption speed and the unrealized potential of eCTD & documents, we believe that PDF will be there for many years to come.

Today’s reality in eCTD submission: PDF

There are many reasons why PDF documents are critical for electronic submissions. Let’s take a moment to see what the eCTD stands for: electronic Common Technical Document. This means that in today’s reality, the worldwide expected format for digital submissions is a document, and not data. While that may change in the future, the creation of a new and improved version for the eCTD, namely eCTD 4.0 only comes to support the idea that documents are not going away and that PDF is here to stay.

Another reason why PDF documents are still crucial for electronic submissions is closely related to the huge volumes of documents that are piled up, especially in the first stages of research, development and testing of a new medicinal product. Imagine how many documents a company has after 14 years of research.

When filing for marketing authorization of a new drug, the company must ensure that each and every one of those documents that will be submitted, is technically compliant with the HA requirements. While that is not an impossible task, it is  extremely time-consuming to do it manually and let’s not overlook the increased risk of human error. This is where a solution like DocShifter comes in: automatically converting all those documents into submission ready PDFs for any health authority in the world.

How are the current eCTD submission formats expected to evolve in the future?

Let’s consider the countries that are currently accepting eCTD submissions. As we mentioned before, the Life Sciences industry, due to the risks involved, is very reluctant to change. Therefore, it took decades to move to the electronic PDF format. Additionally, making this change into electronic submissions took a lot of effort and time from both HAs and companies. 

  • On one hand, there are companies that must be able to create the documents in the required eCTD format while being compliant with any additional requirements imposed by each national HA. 
  • On the other hand, there are the HAs that had to implement the technology needed to be able to review the electronic submissions and also train their employees on using the new technology.

Just consider the financial investments of companies and HAs currently accepting the eCTD submissions or are in the early implementation stages. They would have to cover all costs if they were to move to a new, uncertain and not tested format like data submissions.

It is always good to think about new possibilities, and data submissions can become a reality in the future. However, the era of PDF submissions is still here and is not going anywhere for many years to come. There is still a lot of room for improvement in existing submission processes, starting from how compliant PDFs are generated for submissions. 

This is why the Life Sciences industry should focus on the present and search for better ways to optimize their PDF creation processes for electronic submissions. The creation of fully compliant, submission ready PDFs can be much easier, quicker and with less-risk. Multiple compliant PDFs can be generated simultaneously from 1 source document, simplifying the process of submitting the dossier to multiple HAs. 

Even if parts of what is submitted in PDF will become data gradually, it is still years away from becoming the norm.

 

About the author – Paul Ireland 

Paul Ireland - VP Life Sciences - DocShifter

20+ years in helping to provide regulatory software and service solutions to Life Sciences organisations globally. Industry and commercial experience in delivering Content Rendering, Regulatory Information Management, Submission and Report-level Publishing, and Electronic Document Management solutions. 

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs. Rated 5 starts on Gartner’s Capterra platform. 

Last update: 08/01/2021

Refusal to File (RTF) and how modern rendering can reduce non-compliance risk

Bringing a new medicine or a product to the market is a complex process that typically takes from 8 to 14 years. Although this process may vary from one Health Authority (HA) to another, there are some general stages that the medicine must go through before it can be safely distributed to patients. It starts with research and development (R&D), then slowly moves into the next steps, including assessment and evaluation through non-clinical and clinical trials, filing for marketing authorization to the HA and getting regulatory approval. The final stage is the post-market safety monitoring after the product is launched to the market.

Patient safety is crucial in the Life Sciences industry

There are high risks of taking any shortcuts in this long process. In fact, a study conducted by the Tulane University back in 2003 showed that each 10-month reduction in the US Food and Drugs Administration (FDA) review time period for a new drug can lead to an 18% increase in serious adverse reactions, an 11% increase in drug-related hospitalizations, and a 7.2% increase in drug-related deaths.

Patient safety is the reason why the process of bringing a new drug to the market takes so much time. And since it is the main focus of the entire Life Sciences industry, the new drug can be rejected even before filing for marketing authorization to the HAs if it isn’t considered safe for public use. For example, during the clinical trials, the first phase sees approximately 70% of drugs move to the next step. Phase III trials see only 25-30% of those remaining drugs enter the final stage leading to HA review.

Filing for marketing authorization – is success guaranteed?

Once the drug passes the testing phase, pharmaceutical companies finally reach the stage of submitting a request for authorization to the HA where the drug is going to be marketed. However, there is always a risk of getting a rejection from the HAs.

In fact, research shows that 25% of the marketing applications for drug authorization submitted in the past to the European Medicines Agency (EMA) were rejected. Additionally, looking at the statistics published by the FDA, a total number of 73 refusal-to-file (RTF) letters were issued to non-compliant pharmaceutical companies over a period of 7 years.

One of the main reasons of Refusal to file is the inability to comply with the technical HA requirements.

As explained in one of our previous articles, it takes many years for a new drug to be approved. When the pharmaceutical company is finally able to file for marketing authorization, it must ensure that each document from the millions collected over so many years of research respects all the specific technical requirements from each national HA. This is where an automated document conversion solution like DocShifter can help companies: automatically convert all those documents into submission ready PDFs for any HA in the world and reduce the risk of receiving a Refusal to file.

What are the consequences of receiving a Refusal to file from the FDA?

When a Life Sciences organization’s marketing authorization for a new drug is rejected by the HA for non-compliance, the negative impact can be translated into significant financial losses and damages to the company’s image and reputation. To give you a better understanding of the importance of compliance in the Life Sciences industry, let’s focus on the consequences of receiving an RTF from the FDA.

  1. Fines imposed by the FDA. Under the Prescription Drug User Fee Act (PDUFA), when applying for the approval of a new drug, the pharmaceutical company must pay an application fee (for 2020, the current rates are: $1,471,483 – if no clinical data is required, and $2,942,965 – if clinical data is required). If a drug application is refused for filing, the pharma organization can receive back only 75% of the application fee, incurring financial penalties of $367,871 up to $735,741.
  2. Loss of R&D financial investments. Statistics in the industry show that pharmaceutical companies spend, on average, 17% of their revenue on developing a new drug. This amount translates into an average of $4 billion, and an RTF letter delays (months) in getting the product to market and causing loss of revenue. Even when the company takes actions to become fully compliant with the FDA’s requirements, it will still lose significant amounts of money every day that it doesn’t bring the new drug to the market.
  3. Stock price drops. This is another negative impact that contributes to the significant financial losses incurred after receiving an RTF from the FDA. For example, there was the case with a pharmaceutical company that filed for marketing authorization of its new drug with the FDA in December 2015. Two months later, in February 2016, the company announced that it received an RTF letter from the FDA. Soon after this announcement, the stock prices plummeted by 37.3% in a single day.what can an Refusal to file letter lead to in life sciences? What are the consequences of technical non-compliance? DocShifter
  4. Negative press. Ensuring patient safety is vital in the Life Sciences industry. This means that patients also should be confident in the pharmaceutical company’s ability to bring a new drug to the market that may help improve their lives. If the press discovers that the pharma company’s drug application was refused by the FDA, all that negative buzz can end into losing the customers’ confidence. And when that happens, the consequences can be truly catastrophic and it can really be the end of the new drug, long before being launched to the market.

How can DocShifter help pharmaceutical companies achieve technical compliance?

Pharmaceutical companies can get an RTF for two main reasons: the inability to comply with content requirements (missing information or summaries, appendixes not submitted, etc.) or with technical PDF requirements of that HA. 

Even though there are some tools that can create compliant submission ready PDF documents, they are costly, time-consuming, and have to be manually configured. The DocShifter document conversion software makes sure that your electronic submission documents are fully technically compliant with any HA. Simple, automated, and fast. 

To ease compliance and reduce the risk of Refusal to file, DocShifter software provides technical PDF configurations, that are predefined to the technical requirements of each national HA like the FDA (in the US), EMA (in the EU), PMDA (in Japan), HC (in Canada) and many more. With this, every PDF you generate with DocShifter will exactly match what the HAs demand. 

Compliant, pre-defined PDF configurations to create fully technically PDFs for FDA, EMA, PMDA, HC and many more. Save time, reduce risk of an refusal to file with DocShifter

Discover more

 

About the author – Paul Ireland 

Paul Ireland - VP Life Sciences - DocShifter

20+ years in helping to provide regulatory software and service solutions to Life Sciences organisations globally. Industry and commercial experience in delivering Content Rendering, Regulatory Information Management, Submission and Report-level Publishing, and Electronic Document Management solutions. 

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs. Rated 5 starts on Gartner’s Capterra platform. 

Last update: 08/01/2021

How to speed up PDF conversion by 10X in 2021

Introduction

Compliance is never far away in the Life Sciences industry. The different health authorities across the globe have set out very specific guidelines when it comes to providing documentation and data. For the right reasons. Life Sciences (pharma, biotech and medical devices) companies spend time and effort to ensure that the information supplied meets these requirements. Not an easy task, as documents live in different systems, versions, digital file formats etc. And that is where standardization comes in. The transformation to a neutral, generally recognized file format such as PDF plays a big role here.

During the entire product life cycle in Life Sciences, PDF files (amongst other formats) are created. PDF ensures consistency, helps to standardize across different departments and platforms. Thus, it helps increase efficiency in document centric processes.

The conversion of different file formats to PDF is often also referred to as ‘document rendering’. Converting documents is generally handled by very specific applications & systems, the so called ‘rendition engines’. This ensures the transformation of one digital file format into another, f.e. PDF.

Document rendering can be done in different ways. The most common approaches are:

  1. By making use of the ‘authoring’ application that was used to author the original document (Microsoft Word, OpenOffice, Microsoft Excel, etc.)
  2. Standalone document rendering, without using the authoring application(s).

Both approaches are very different, and vary greatly in terms of speed, quality, configurability. This article further explains the inherent differences of both. 

Rendering through the use of the authoring application (f.e. Office, Adobe, …)

This approach is being used today by most organizations and is the most common way of creating a PDF. As an example, this is what happens during a Word to PDF conversion with this approach.

  1. The first step is to retrieve the Word file from where it resides. Within large organizations, content can be stored in multiple places: Document Management Systems (DMS) such as: OpenText Documentum, Veeva, Microsoft SharePoint, Box, Alfresco, Generis CARA, Hyland etc. 
  2. The rendering engine connects to the existing Document Management System(s) and pulls the original Word file from there. Or the file is being sent over.
  3. The rendering engine then calls the authoring application (for a Word file, the authoring application is Microsoft Word. For PowerPoint, is Microsoft PowerPoint etc.) to open the original source file.
  4. Subsequently it performs a Print to Postscript action using an Adobe Distiller or other printer driver. 
  5. The rendering server then starts Adobe Distiller or equivalent and the Postscript file loaded, which is then converted to PDF. 
  6. All authoring and Adobe applications are finally closed, and the PDF is sent back to the Document Management System(s). 
  7. The PDF file is stored as a rendition to the original Word document or as a new object. 
  8. The process then repeats for the next Word file.

Why should you not convert to PDF using authoring and native applications?

So far, so good. The conversion of a Word file to PDF through the authoring application. But, what happens in reality?

” Rendering by using the authoring application
introduces risks.”

Based on the conversations with industry experts, and our customers, this approach has drawbacks:

  1. The authoring applications (Office and Adobe tools and everything else) need licenses. And these come at a price. The number of documents to be converted and the organization size impacts licensing cost. All these authoring applications must also be upgraded, patched and validated. All in all, this brings big (and often overlooked) costs for most organizations. Especially when you consider how many different formats should be converted to PDF. (PowerPoint, Excel, Word etc.)
  2. Rendering through the use of the authoring applications introduces risks. A simple version difference (Word version installed on the desktop vs. Word version installed on the rendition server) can cause all PDF conversions to fail, potentially bringing the entire process to a stop. In some cases, Word documents containing specific settings, have caused the rendition server to inherit these settings, causing incorrect renditions.
  3. Rendering through the use of the authoring applications is slow and burdensome: For every PDF conversion request, the authoring application opens the source file(s). This process, multiplied by thousands of documents for each submission package, can add up to weeks or longer.

Document conversion is being used by many departments (marketing, HR, labelling, regulatory etc.) throughout a large organization. A slow or failed conversion process quickly becomes very costly

Time to market is critical, so coming up with solutions to the above challenges is key.  PDF conversion should be easy, automated and as cost-efficient as possible.

‘’Rendering through the authoring applications is risky, expensive and slow. Is there a more efficient way?’’

Standalone document rendering

There is. DocShifter doesn’t need any authoring applications to perform PDF or any other conversions. Thanks to this architecture, our customers see a 66% cost reduction in IT infrastructure. (licensing, number of servers etc.) Risks associated with authoring applications (slow conversions, extra costs, manual interventions etc.) are simply eliminated. 

Convert word to PDF with authoring applications. Fast, simple, automated document and content conversion with DocShifter

Moreover, DocShifter doesn’t need any authoring applications to run. This significantly improves the conversion speed: 10x faster than comparable solutions.

Docker container technology further empowers the document conversion capabilities of DocShifter. When organizations have the pressure to convert thousands or millions of documents in a very short amount of time, peak loads are easily dealt with.

DocShifter’s standard configurations for FDA, PMDA, EMA and other health authorities allow consistent and automated submission-ready PDF creation. In one go. 

Thanks to native integrations and open API’s, DocShifter connects with any DMS or RIM system. This open connectivity greatly reduces the risk and increases the efficiency, as content is stored in multiple repositories. Document conversion is centralized in 1 platform, for all departments. 

 

About the author – Paul Ireland 

Paul Ireland - VP Life Sciences - DocShifter

20+ years in helping to provide regulatory software and service solutions to Life Sciences organisations globally. Industry and commercial experience in delivering Content Rendering, Regulatory Information Management, Submission and Report-level Publishing, and Electronic Document Management solutions. 

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs.

Interested to see how? Check our 30-min. webinar on how modern rendering saves time and reduces risk of non-compliance. See real-life examples from your peers and how Life Sciences companies of any size benefit from modern rendering technologies.

reduce risk of non compliance webinar

DocShifter 6.3 is rocking rendering again with new and improved functionality

DocShifter 6.3 was born as a result of our development team’s hard work. This release is very special to us, not only because it adds up to industry leading rendering capabilities but also because of how it was built. 6.3 was built completely remotely, as entire team was working from home. Impressive work.

DocShifter 6.3 focuses on improving ease of use, end user communications, administration, and performance. We are happy to share the highlights with you.

Improved end user satisfaction

  • Allow for direct communication between the authors of the content and the status of their transformations. Email notifications can now be sent to the individuals that requested the rendition and/or the user that last checked the document in.
  • Improved handling of Excel, text and PDF/A based files. Defining page sizes and punctuation characters plus more automated encoding detection as well as ensuring complete accuracy to the desired PDF/A compliance level.
  • Enhanced handling of grouped bookmarks reduces the time needed in manual formatting of the results.
  • Better workflow handling of Virtual Documents where concatenated renditions are required. Integrate Virtual Document processing- which was first introduced in DocShifter 6.2.5- into your more complex workflows.

Improved administration

  • Quickly and easily view the status of all your workflows and allow for instant enabling/disabling from the workflow list. This improves the general usability in a production environment.
  • Export all your workflows at once, saving time with upgrades & migrations.
  • Easily identify which configuration parameters are mandatory, saving time when setting up new workflows.
  • Easily identify which DocShifter server (where multiple servers are in use) an email notification was sent from. Speed up your error investigation processes.

Additional improvements have been made to increase performance and handling of the huge quantities of diverse content DocShifter is expected to process on a daily basis. Please refer to the release notes available on the customer portal for full details of this exciting new release.

Stay tuned for the release of our new Table of Contents module in the coming weeks.

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs.

Interested to see how? Check our 30-min. webinar on how modern rendering saves time and reduces risk of non-compliance. See real-life examples from your peers and how Life Sciences companies of any size benefit from modern rendering technologies.

You can easily register below to access the recording.

modern rendering

PeopleScout significantly improves efficiency and speed in document and PDF conversion with DocShifter

PeopleScout Technology, a world leader in recruitment process outsourcing (RPO) has recently chosen DocShifter to convert all incoming digital formats to high quality PDF files. System administrator Chris Bellgard explains the impact of this decision at PeopleScout with numbers.

How did automated document and PDF conversion impact Chris’ daily activities at PeopleScout?

DocShifter is the world’s fastest enterprise-grade any-to-any conversion software. Conversions include but are not limited to: Office and text file formats, mark-up file formats, PDF formats, e-mail formats, compressed file formats, audio and video formats, image file formats, OCR file formats and Microsoft project file formats.

Are you converting 100.000s of documents and looking for a faster way of doing so?

See our solutions

 

DocShifter powers the document conversion solution in Generis new CARA cloud offering

We are happy to announce our DocShifter software will be the default enterprise document conversion solution in Generis’ new CARA cloud offering. The integration will further strengthen the bond between organizations and allows the new CARA to serve a larger range of clients with expanded document conversion functionalities.

New CARA cloud offering provides an enterprise content and information platform, able to store and manage data both in CARA as well as that stored in a range of other repositories.  While the integration has been available for classic CARA for some time, it will now be the default option for the New CARA Cloud platform for customers requiring rendering meeting a range of complex requirements of regulated industries. 

DocShifter solution automates any-to-any conversions with support for 300 input and output formats. The speed, scalability and connectivity with all DMS & RIM systems make DocShifter technology an essential for Life Sciences organizations that deal with complex content and document conversion requirements. 

 “With the integration of DocShifter as the default document conversion solution into the new CARA, we are able deliver our promise even better: drastically speeding up and simplifying the complex process of content and document conversion. DocShifter’s document conversion capabilities, combined with new CARA, are able to answer the complex requirements of highly regulated industries,” states Geert van Peteghem, CEO of DocShifter. 

“We already support many joint customers who have advanced document conversion requirements met by the integration of DocShifter with CARA,” said James Kelleher CEO of Generis. “We are now happy to be able to offer this on a pre-built package with New CARA on our cloud for such customers.”

About DocShifter

DocShifter

DocShifter was created in 2007 to respond to the need for easy and fast content conversion in highly regulated environments. Customers can be found worldwide in Life Sciences, Public Sector, Engineering, Banking & Insurance. The company is headquartered in Ghent, Belgium.

At DocShifter, we believe that relevant digital content should never become obsolete. Unstructured information needs to be kept in a readable and searchable format, for generations to come. In our fast-paced digital world, standards appear and disappear. Transforming all this digital content, in whatever shape or form is our goal. To ensure your information continues to provide value.

About Generis 

Generis is a global leader in content and information management systems, specialising in proven solutions for regulated industries. Established in 1997 as a consultancy group, Generis has since grown and developed alongside its flagship product CARA. Our mission is to provide a platform which is highly configurable and user friendly; a dedicated team works hard to guarantee customer satisfaction. Currently counting over 450,000 users across numerous industries worldwide, including 8 of the 10 largest Life Science companies, CARA continues to progress to become the answer for end-to-end data management. 

To find out more visit: www.generiscorp.com

About DocShifter

Speed, quality, scalability, and configurability are reasons why Life Sciences organizations choose DocShifter to generate technically compliant, submission-ready PDF. High volume, high-quality document conversion, on-premises, or in the cloud. Super easy to set up. Automate. Centralize. Eliminate manual intervention. Reduce Risk. Reduce IT infrastructure costs.

Interested to see how? Check our 30-min. webinar on how modern rendering saves time and reduces risk of non-compliance. See real-life examples from your peers and how Life Sciences companies of any size benefit from modern rendering technologies.

You can easily register below to access the recording.

modern rendering